Calliditas Therapeutics AB (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
19.45
0.99 (5.36%)
At close: May 20, 2022 4:00 PM
18.70
-0.75 (-3.86%)
After-hours:May 20, 2022 5:05 PM EDT
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2021 | 2020 |
|---|---|---|---|
| Market Capitalization | 517 | 618 | 778 |
| Market Cap Growth | - | -20.55% | - |
| Enterprise Value | 435 | 536 | 668 |
| PE Ratio | - | -11.12 | -14.72 |
| PS Ratio | 20.29 | 24.26 | 7.00 |
| PB Ratio | 4.62 | 5.52 | 5.27 |
| EV/Sales Ratio | 17.06 | 21.10 | 5.00 |
| Debt / Equity Ratio | 0.21 | 0.21 | 0.00 |
| Debt / EBITDA Ratio | -0.43 | -0.43 | 0.00 |
| Debt / FCF Ratio | -0.46 | -0.46 | 0.00 |
| Current Ratio | 7.48 | 7.48 | 9.82 |
| Asset Turnover | 0.16 | 0.16 | 0.00 |
| Return on Equity (ROE) | -45.10% | -45.10% | -36.60% |
| Return on Assets (ROA) | -34.20% | -34.20% | -33.50% |
| Return on Capital (ROIC) | -780.60% | -780.60% | 971.20% |
| Earnings Yield | -10.75% | -8.99% | -6.79% |
| FCF Yield | -10.06% | -8.41% | -4.84% |
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).